News Column

United States : Carl Zeiss Meditec AG records growth in all business units

August 14, 2014

In the first nine months of financial year 2013/2014 medical technology company Carl Zeiss Meditec AG increased its revenue to 673.7 million After adjustment for exchange rates this corresponds to growth of 7.3 percent; at the end of the day, considering the significant negative impact from currency translation effects which were also present in previous quarters, revenue lifted by 3.8 percent compared to the same period of the previous year. Growth in EBIT (EUR 92.1 million) and the EBIT margin (13.7 percent) were also hampered by currency translation effects. As already reported, a neutral result from currency hedging transactions based on the nine-month period led to earnings per share (EPS) falling by 13.5 percent.

Our business continued to show a positive development in the past few months. All three strategic business units (SBUs) contributed to the growth, commented Dr. Ludwin Monz, Carl Zeiss Meditec AG s CEO. As in the previous months, unfavorable exchange rates had an exceptionally adverse impact on business.

Once again, the Surgical Ophthalmology SBU recorded the strongest revenue growth. During the period under review, this SBU s revenues lifted by around 22 percent year-on-year, with additional support from the acquisition of the Aaren Scientific, which specializes in intraocular lenses, and continued strong demand for innovative intraocular lenses in the premium segment. Even without considering the figures for Aaren Scientific, included for the first time, this business unit recorded substantial double-digit growth.

Revenues in the Microsurgery SBU were up slightly year-on-year, with a continued strong adverse impact from exchange rates in the first nine months of the current financial year. After currency adjustments, surgical microscopes and visualization solutions grew by 5.9 percent.

The Ophthalmic Systems SBU was able to keep its revenues at almost the previous year s level. After adjustment for currency translation, this SBU contributed growth of 3.6 percent, with continued strong pressure from the competition in diagnostics and a high level of demand for innovative lasers for refractive vision correction.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: TendersInfo (India)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters